Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   cholelithiasis
  

Disease ID 539
Disease cholelithiasis
Definition
Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS).
Synonym
biliary calculi
biliary calculus
biliary calculus (disorder)
biliary calculus (disorder) [ambiguous]
biliary calculus, nos
calculus - biliary
calculus in biliary tract
calculus in biliary tract (disorder)
calculus of gallbladder
cholelith
cholelithiases
cholelithiasis [disease/finding]
cholelithiasis nos (disorder)
cholelithiasis, nos
cl - cholelithiasis
gall stone
gall stones
gallbladder stone
gallbladder stones
gallstone
gallstone disease
gallstone, nos
gallstones
gallstones [disease/finding]
stone - biliary
stones - gall
DOID
UMLS
C0008350
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:108)
C0008325  |  cholecystitis  |  36
C0030305  |  pancreatitis  |  16
C0948265  |  metabolic syndrome  |  10
C0001339  |  acute pancreatitis  |  8
C0153452  |  gallbladder ca  |  8
C0005684  |  bladder cancer  |  7
C0008370  |  cholestasis  |  7
C0023890  |  cirrhosis  |  7
C0023890  |  liver cirrhosis  |  6
C0028754  |  obesity  |  6
C0011847  |  diabetes  |  6
C0153452  |  gallbladder cancer  |  6
C0021843  |  intestinal obstruction  |  5
C0001173  |  gastric outlet obstruction  |  4
C0021843  |  bowel obstruction  |  4
C0022354  |  obstructive jaundice  |  4
C0008311  |  cholangitis  |  4
C0701818  |  choledocholithiasis  |  3
C0699885  |  bladder carcinoma  |  3
C0011849  |  diabetes mellitus  |  3
C0042373  |  vascular disease  |  3
C0002895  |  sickle cell disease  |  3
C0007222  |  cardiovascular disease  |  3
C0007113  |  rectal cancer  |  3
C0206698  |  cholangiocarcinoma  |  3
C0008350  |  cholelithiasis  |  3
C0008350  |  gallstones  |  3
C1258215  |  ileus  |  3
C0238137  |  gallbladder adenoma  |  3
C0037889  |  hereditary spherocytosis  |  2
C0010346  |  crohn's disease  |  2
C0009402  |  colorectal cancer  |  2
C0013292  |  duodenal obstruction  |  2
C0018920  |  cavernoma  |  2
C0011860  |  type 2 diabetes  |  2
C0023895  |  liver disease  |  2
C0039730  |  thalassemia  |  2
C0041466  |  typhoid  |  2
C0023903  |  liver cancer  |  2
C0024623  |  gastric cancer  |  2
C0235782  |  gallbladder carcinoma  |  2
C0002871  |  anemia  |  2
C0008350  |  gallstone  |  2
C0013295  |  duodenal ulcer  |  1
C0014848  |  achalasia  |  1
C0024790  |  paroxysmal nocturnal hemoglobinuria  |  1
C0010674  |  cystic fibrosis  |  1
C0022661  |  end stage renal disease  |  1
C0018799  |  heart disease  |  1
C0024299  |  lymphoma  |  1
C0021390  |  inflammatory bowel diseases  |  1
C0013395  |  indigestion  |  1
C0002878  |  haemolytic anaemia  |  1
C0009319  |  colitis  |  1
C0004623  |  bacterial infection  |  1
C0002878  |  hemolytic anemia  |  1
C0016977  |  gallbladder diseases  |  1
C0002895  |  sickle cell anemia  |  1
C0154251  |  lipid disorders  |  1
C0267924  |  suppurative cholangitis  |  1
C0037661  |  somatostatinoma  |  1
C0153452  |  gall bladder cancer  |  1
C0004763  |  barrett's esophagus  |  1
C0016977  |  gallbladder disease  |  1
C0011860  |  type 2 diabetes mellitus  |  1
C0020224  |  polyhydramnios  |  1
C0019196  |  hepatitis c  |  1
C0850572  |  colonic adenoma  |  1
C0162316  |  iron-deficiency anemia  |  1
C0042373  |  vascular diseases  |  1
C0009324  |  ulcerative colitis  |  1
C0011570  |  depression  |  1
C0162316  |  iron deficiency anemia  |  1
C0015645  |  fasciitis  |  1
C0008370  |  biliary stasis  |  1
C0035078  |  renal failure  |  1
C0221002  |  primary hyperparathyroidism  |  1
C0014858  |  esophageal motility disorders  |  1
C0013384  |  dyskinesia  |  1
C0267917  |  acute cholangitis  |  1
C0016977  |  biliary disease  |  1
C0152021  |  congenital heart disease  |  1
C0005403  |  bile reflux  |  1
C0345916  |  ampullary tumor  |  1
C0235974  |  pancreatic cancer  |  1
C0008372  |  intrahepatic cholestasis  |  1
C0017205  |  gaucher disease  |  1
C0085693  |  acute appendicitis  |  1
C0007222  |  cardiovascular diseases  |  1
C0014848  |  esophageal achalasia  |  1
C0010346  |  crohn disease  |  1
C0235782  |  gall bladder carcinoma  |  1
C0022661  |  chronic renal failure  |  1
C0162871  |  abdominal aortic aneurysm  |  1
C0022658  |  renal disease  |  1
C0024299  |  lymphomas  |  1
C0023890  |  hepatic cirrhosis  |  1
C0005683  |  bladder stone  |  1
C0021390  |  inflammatory bowel disease  |  1
C0149521  |  relapsing pancreatitis  |  1
C0003486  |  aortic aneurysm  |  1
C0005416  |  biliary dyskinesia  |  1
C0025164  |  megaesophagus  |  1
C0014013  |  thoracic empyema  |  1
C0021831  |  bowel disease  |  1
C0008370  |  bile duct obstruction  |  1
C0019322  |  umbilical hernia  |  1
C0024110  |  lung abscess  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:3)
ABCG8  |  64241  |  GWASCAT
ABCG5  |  64240  |  GWASCAT
ASPG  |  374569  |  CTD_human
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:20)
8647  |  ABCB11  |  infer
5244  |  ABCB4  |  infer
338  |  APOB  |  infer
348  |  APOE  |  infer
886  |  CCKAR  |  infer
1071  |  CETP  |  infer
1581  |  CYP7A1  |  infer
3043  |  HBB  |  infer
3949  |  LDLR  |  infer
100507436  |  MICA  |  infer
10062  |  NR1H3  |  infer
54658  |  UGT1A1  |  infer
64240  |  ABCG5  |  infer
64241  |  ABCG8  |  infer
335  |  APOA1  |  infer
337  |  APOA4  |  infer
341  |  APOC1  |  infer
345  |  APOC3  |  infer
4023  |  LPL  |  infer
4043  |  LRPAP1  |  infer
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:166)
1080  |  CFTR  |  DISEASES
6344  |  SCTR  |  DISEASES
634  |  CEACAM1  |  DISEASES
6343  |  SCT  |  DISEASES
4680  |  CEACAM6  |  DISEASES
2099  |  ESR1  |  DISEASES
26499  |  PLEK2  |  DISEASES
140679  |  SLC32A1  |  DISEASES
10857  |  PGRMC1  |  DISEASES
27344  |  PCSK1N  |  DISEASES
27120  |  DKKL1  |  DISEASES
2091  |  FBL  |  DISEASES
973  |  CD79A  |  DISEASES
1048  |  CEACAM5  |  DISEASES
5539  |  PPY  |  DISEASES
3732  |  CD82  |  DISEASES
338  |  APOB  |  DISEASES
7276  |  TTR  |  DISEASES
3007  |  HIST1H1D  |  DISEASES
6555  |  SLC10A2  |  DISEASES
7355  |  SLC35A2  |  DISEASES
2678  |  GGT1  |  DISEASES
15  |  AANAT  |  DISEASES
3630  |  INS  |  DISEASES
348  |  APOE  |  DISEASES
10343  |  PKDREJ  |  DISEASES
8431  |  NR0B2  |  DISEASES
1401  |  CRP  |  DISEASES
83998  |  REG4  |  DISEASES
10599  |  SLCO1B1  |  DISEASES
80896  |  NPL  |  DISEASES
3569  |  IL6  |  DISEASES
64240  |  ABCG5  |  DISEASES
949  |  SCARB1  |  DISEASES
114294  |  LACTB  |  DISEASES
10483  |  SEC23B  |  DISEASES
5465  |  PPARA  |  DISEASES
6929  |  TCF3  |  DISEASES
2549  |  GAB1  |  DISEASES
8647  |  ABCB11  |  DISEASES
3299  |  HSF4  |  DISEASES
23530  |  NNT  |  DISEASES
4547  |  MTTP  |  DISEASES
5244  |  ABCB4  |  DISEASES
6713  |  SQLE  |  DISEASES
11001  |  SLC27A2  |  DISEASES
64241  |  ABCG8  |  DISEASES
167410  |  LIX1  |  DISEASES
51302  |  CYP39A1  |  DISEASES
23196  |  FAM120A  |  DISEASES
5741  |  PTH  |  DISEASES
92935  |  MARS2  |  DISEASES
4154  |  MBNL1  |  DISEASES
6326  |  SCN2A  |  DISEASES
5205  |  ATP8B1  |  DISEASES
4838  |  NODAL  |  DISEASES
7547  |  ZIC3  |  DISEASES
6750  |  SST  |  DISEASES
23420  |  NOMO1  |  DISEASES
3156  |  HMGCR  |  DISEASES
3815  |  KIT  |  DISEASES
29881  |  NPC1L1  |  DISEASES
23387  |  SIK3  |  DISEASES
1990  |  CELA1  |  DISEASES
9965  |  FGF19  |  DISEASES
10630  |  PDPN  |  DISEASES
51072  |  MEMO1  |  DISEASES
886  |  CCKAR  |  DISEASES
213  |  ALB  |  DISEASES
7047  |  TGM4  |  DISEASES
200931  |  SLC51A  |  DISEASES
4724  |  NDUFS4  |  DISEASES
6690  |  SPINK1  |  DISEASES
23588  |  KLHDC2  |  DISEASES
1581  |  CYP7A1  |  DISEASES
4255  |  MGMT  |  DISEASES
3479  |  IGF1  |  DISEASES
54578  |  UGT1A6  |  DISEASES
54658  |  UGT1A1  |  DISEASES
6579  |  SLCO1A2  |  DISEASES
83886  |  PRSS27  |  DISEASES
3159  |  HMGA1  |  DISEASES
2147  |  F2  |  DISEASES
23209  |  MLC1  |  DISEASES
9420  |  CYP7B1  |  DISEASES
3952  |  LEP  |  DISEASES
64755  |  C16orf58  |  DISEASES
63951  |  DMRTA1  |  DISEASES
4018  |  LPA  |  DISEASES
25915  |  NDUFAF3  |  DISEASES
199699  |  DAND5  |  DISEASES
55748  |  CNDP2  |  DISEASES
7433  |  VIPR1  |  DISEASES
346389  |  MACC1  |  DISEASES
10456  |  HAX1  |  DISEASES
3855  |  KRT7  |  DISEASES
2520  |  GAST  |  DISEASES
212  |  ALAS2  |  DISEASES
3043  |  HBB  |  DISEASES
2152  |  F3  |  DISEASES
123264  |  SLC51B  |  DISEASES
885  |  CCK  |  DISEASES
9138  |  ARHGEF1  |  DISEASES
9376  |  SLC22A8  |  DISEASES
23436  |  CELA3B  |  DISEASES
51337  |  THEM6  |  DISEASES
7180  |  CRISP2  |  DISEASES
4521  |  NUDT1  |  DISEASES
132884  |  EVC2  |  DISEASES
400673  |  VMAC  |  DISEASES
54575  |  UGT1A10  |  DISEASES
2100  |  ESR2  |  DISEASES
5498  |  PPOX  |  DISEASES
5265  |  SERPINA1  |  DISEASES
3240  |  HP  |  DISEASES
146059  |  CDAN1  |  DISEASES
4047  |  LSS  |  DISEASES
56980  |  PRDM10  |  DISEASES
56955  |  MEPE  |  DISEASES
58  |  ACTA1  |  DISEASES
5362  |  PLXNA2  |  DISEASES
7432  |  VIP  |  DISEASES
2494  |  NR5A2  |  DISEASES
462  |  SERPINC1  |  DISEASES
336  |  APOA2  |  DISEASES
3068  |  HDGF  |  DISEASES
6280  |  S100A9  |  DISEASES
7390  |  UROS  |  DISEASES
9557  |  CHD1L  |  DISEASES
1244  |  ABCC2  |  DISEASES
959  |  CD40LG  |  DISEASES
27095  |  TRAPPC3  |  DISEASES
54576  |  UGT1A8  |  DISEASES
414189  |  AGAP6  |  DISEASES
84557  |  MAP1LC3A  |  DISEASES
177  |  AGER  |  DISEASES
9356  |  SLC22A6  |  DISEASES
1114  |  CHGB  |  DISEASES
3045  |  HBD  |  DISEASES
3030  |  HADHA  |  DISEASES
1854  |  DUT  |  DISEASES
3486  |  IGFBP3  |  DISEASES
438  |  ASMT  |  DISEASES
283820  |  NOMO2  |  DISEASES
192668  |  CYS1  |  DISEASES
2235  |  FECH  |  DISEASES
2172  |  FABP6  |  DISEASES
2875  |  GPT  |  DISEASES
408050  |  NOMO3  |  DISEASES
57708  |  MIER1  |  DISEASES
728441  |  GGT2  |  DISEASES
2641  |  GCG  |  DISEASES
4295  |  MLN  |  DISEASES
119016  |  AGAP4  |  DISEASES
642517  |  AGAP9  |  DISEASES
54659  |  UGT1A3  |  DISEASES
8801  |  SUCLG2  |  DISEASES
80012  |  PHC3  |  DISEASES
6091  |  ROBO1  |  DISEASES
151306  |  GPBAR1  |  DISEASES
9404  |  LPXN  |  DISEASES
26298  |  EHF  |  DISEASES
9  |  NAT1  |  DISEASES
9971  |  NR1H4  |  DISEASES
27229  |  TUBGCP4  |  DISEASES
57000  |  GSN-AS1  |  DISEASES
Locus(Waiting for update.)
Disease ID 539
Disease cholelithiasis
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:70)
HP:0001082  |  Cholecystitis  |  38
HP:0001733  |  Pancreatic inflammation  |  18
HP:0005214  |  Bowel obstruction  |  12
HP:0001735  |  Acute pancreatitis  |  9
HP:0012531  |  Pain  |  9
HP:0001394  |  Hepatic cirrhosis  |  8
HP:0001396  |  Cholestasis  |  7
HP:0009725  |  Bladder neoplasm  |  7
HP:0001696  |  Situs inversus totalis  |  6
HP:0001513  |  Obesity  |  6
HP:0030151  |  Cholangitis  |  5
HP:0030731  |  Carcinoma  |  5
HP:0002027  |  Abdominal pain  |  5
HP:0001081  |  Gallstones  |  5
HP:0000855  |  Insulin resistance  |  4
HP:0030153  |  Cholangiocarcinoma  |  4
HP:0002595  |  Gastrointestinal atony  |  4
HP:0001397  |  Hepatic steatosis  |  3
HP:0002862  |  Bladder carcinoma  |  3
HP:0000819  |  Diabetes mellitus  |  3
HP:0005608  |  Double gallbladder  |  2
HP:0003774  |  End-stage renal failure  |  2
HP:0002664  |  Neoplasia  |  2
HP:0002896  |  Liver cancer  |  2
HP:0001903  |  Anemia  |  2
HP:0100280  |  Morbus Crohn  |  2
HP:0100790  |  Hernia  |  2
HP:0001878  |  Haemolytic anaemia  |  2
HP:0000952  |  Yellow skin  |  2
HP:0012126  |  Gastric cancer  |  2
HP:0100592  |  Peritoneal abscess  |  2
HP:0001744  |  Splenomegaly  |  1
HP:0002617  |  Aneurysmal dilatation  |  1
HP:0100570  |  Carcinoid tumor  |  1
HP:0011458  |  Abdominal symptom  |  1
HP:0003363  |  Situs inversus viscerum  |  1
HP:0001406  |  Intrahepatic cholestasis  |  1
HP:0008200  |  Primary hyperparathyroidism  |  1
HP:0002894  |  Neoplasia of the pancreas  |  1
HP:0100660  |  Dyskinesis  |  1
HP:0100580  |  Barrett's esophagus  |  1
HP:0004953  |  Abdominal aortic aneurysm  |  1
HP:0100819  |  Intestinal fistula  |  1
HP:0000083  |  Renal insufficiency  |  1
HP:0001537  |  Umbilical hernias  |  1
HP:0001561  |  Hydramnios  |  1
HP:0004942  |  Aortic aneurysm  |  1
HP:0004786  |  Jejunal diverticula  |  1
HP:0100523  |  Hepatic abscess  |  1
HP:0002583  |  Colitis  |  1
HP:0012281  |  Chylous ascites  |  1
HP:0100279  |  Ulcerative colitis  |  1
HP:0002571  |  Achalasia  |  1
HP:0030154  |  Gall bladder perforation  |  1
HP:0000969  |  Dropsy  |  1
HP:0100537  |  Inflammation of the fascia  |  1
HP:0100762  |  Hemobilia  |  1
HP:0002588  |  Duodenal ulcer  |  1
HP:0000716  |  Depression  |  1
HP:0002240  |  Enlarged liver  |  1
HP:0001748  |  Polysplenia  |  1
HP:0004796  |  Gastrointestinal obstruction  |  1
HP:0001891  |  Iron-deficiency anemia  |  1
HP:0012396  |  Biliary dyskinesia  |  1
HP:0001541  |  Ascites  |  1
HP:0011139  |  Gastric duplication  |  1
HP:0004818  |  Paroxysmal nocturnal hemoglobinuria  |  1
HP:0000787  |  Renal calculi  |  1
HP:0002665  |  Lymphoma  |  1
HP:0002910  |  Elevated transaminases  |  1
Disease ID 539
Disease cholelithiasis
Manually Symptom(Waiting for update.)
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:30)
C0008325  |  cholecystitis  |  32
C0030305  |  pancreatitis  |  18
C0085694  |  chronic cholecystitis  |  16
C0149520  |  acute cholecystitis  |  14
C0001339  |  acute pancreatitis  |  9
C0030193  |  pain  |  8
C0021843  |  intestinal obstruction  |  6
C0153452  |  gallbladder cancer  |  5
C0021843  |  bowel obstruction  |  5
C0023890  |  cirrhosis  |  5
C0001173  |  gastric outlet obstruction  |  4
C1258215  |  ileus  |  4
C0701818  |  choledocholithiasis  |  3
C0267898  |  cholecystoduodenal fistula  |  2
C0022346  |  jaundice  |  2
C0037889  |  hereditary spherocytosis  |  2
C0232492  |  upper abdominal pain  |  2
C0013292  |  duodenal obstruction  |  2
C0235782  |  gallbladder carcinoma  |  2
C0009450  |  infection  |  2
C0022354  |  obstructive jaundice  |  1
C0008311  |  cholangitis  |  1
C0235329  |  small bowel obstruction  |  1
C0149521  |  relapsing pancreatitis  |  1
C0006741  |  biliary colic  |  1
C0016169  |  fistula  |  1
C0796095  |  c syndrome  |  1
C0008350  |  gallstones  |  1
C0008370  |  cholestasis  |  1
C0009814  |  stenosis  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:54)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs118875342106297164241ABCG8umls:C0008350BeFreeOur findings suggest that ABCG8 rs11887534, identified as a gallstone risk single-nucleotide polymorphism by whole genome scan, is also associated with an increased risk of biliary tract cancer.0.1488277152011ABCG5;ABCG8243839108GA,C
rs118875342127488464241ABCG8umls:C0008350BeFreeTo test the hypothesis that ABCG8 (adenosine triphosphate-binding cassette transporter G8) Asp19His (D19H) genotype predicted risk of gallstones and biliary cancer in the general population, we studied 62,279 white individuals from The Copenhagen City Heart Study and The Copenhagen General Population Study, randomly selected to reflect the adult Danish population aged 20 to 80+ years.0.1488277152011ABCG5;ABCG8243839108GA,C
rs118875341762626664241ABCG8umls:C0008350BeFreeConsistent with the mouse model, heterozygosity for the lithogenic ABCG8 allele was associated with gallstones in humans; 21.4% of gallstone patients carried the heterozygous D19H genotype, compared with 8.6% of controls (OR = 2.954; P = 0.026).0.1488277152007ABCG5;ABCG8243839108GA,C
rs118875341845735364240ABCG5umls:C0008350BeFreeSignificant association of ABCG5 604Q and ABCG8 D19H polymorphisms with gallstone disease.0.1324539892008ABCG5;ABCG8243839108GA,C
rs118875341763250964240ABCG5umls:C0008350GAD[A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease.]0.1324539892007ABCG5;ABCG8243839108GA,C
rs118875342425650764240ABCG5umls:C0008350BeFreeABCG5 rs6756629 is in strong linkage disequilibrium with rs11887534 (D19H), a variant previously associated with gallstone disease risk in populations of European-descent.0.1324539892013ABCG5;ABCG8243839108GA,C
rs118875341763250964240ABCG5umls:C0008350GWASCATA genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease.0.1324539892007ABCG5;ABCG8243839108GA,C
rs118875341761251564240ABCG5umls:C0008350BeFreeTo investigate a possible association between transporter gene polymorphism and gallstone formation, we examined five common polymorphisms in the ABCG5 (Q604E) and ABCG8 (D19H, Y54C, T400K, A632V) genes in patients with gallstone disease (GS).0.1324539892007ABCG5;ABCG8243839108GA,C
rs11887534201637765244ABCB4umls:C0008350BeFreeIn our study we investigated the contribution of heterozygosity for common variations considered either potentially pathogenic or susceptibility alleles for cholesterol cholelithiasis in adults (c.523A>G (p.Thr175Ala) and c.1954A>G (p.Arg652Gly) in ABCB4, c.1331T>C (p.Val444Ala) in ABCB11 and c.55 G>C (p.Asp19His) in ABCG8) to the aetiology of paediatric idiopathic gallstone disease.0.0176312472010ABCG5;ABCG8243839108GA,C
rs11887534201637768647ABCB11umls:C0008350BeFreeIn our study we investigated the contribution of heterozygosity for common variations considered either potentially pathogenic or susceptibility alleles for cholesterol cholelithiasis in adults (c.523A>G (p.Thr175Ala) and c.1954A>G (p.Arg652Gly) in ABCB4, c.1331T>C (p.Val444Ala) in ABCB11 and c.55 G>C (p.Asp19His) in ABCG8) to the aetiology of paediatric idiopathic gallstone disease.0.0060912732010ABCG5;ABCG8243839108GA,C
rs118875341852262364241ABCG8umls:C0008350BeFreeVarious polymorphisms (A632V, T400K, D19H, M429V, and C54Y) in the ABCG8 and ABCG5 (Q604E) gene have been found to be associated with several facets of cholesterol metabolism, including baseline cholesterol level, cholesterol kinetics, individual responsiveness of plasma cholesterol to dietary and pharmaceutical interventions for hypercholesterolemia, and increased risk of gallstones.0.1488277152008ABCG5;ABCG8243839108GA,C
rs118875341763250964241ABCG8umls:C0008350GAD[A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease.]0.1488277152007ABCG5;ABCG8243839108GA,C
rs118875342103983864241ABCG8umls:C0008350BeFreeRole of ABCG8 D19H (rs11887534) variant in gallstone susceptibility in northern India.0.1488277152010ABCG5;ABCG8243839108GA,C
rs118875342016377664241ABCG8umls:C0008350BeFreeIn our study we investigated the contribution of heterozygosity for common variations considered either potentially pathogenic or susceptibility alleles for cholesterol cholelithiasis in adults (c.523A>G (p.Thr175Ala) and c.1954A>G (p.Arg652Gly) in ABCB4, c.1331T>C (p.Val444Ala) in ABCB11 and c.55 G>C (p.Asp19His) in ABCG8) to the aetiology of paediatric idiopathic gallstone disease.0.1488277152010ABCG5;ABCG8243839108GA,C
rs118875342049729364240ABCG5umls:C0008350BeFreeRecently, variants of the hepatocanalicular cholesterol hemitransporters ABCG5/8 were linked to gallstone disease; ABCG8 D19H in Caucasians and ABCG5 Q604E in Chinese.0.1324539892010ABCG5;ABCG8243839108GA,C
rs118875341845735364241ABCG8umls:C0008350BeFreeSignificant association of ABCG5 604Q and ABCG8 D19H polymorphisms with gallstone disease.0.1488277152008ABCG5;ABCG8243839108GA,C
rs118875342049729364241ABCG8umls:C0008350BeFreeGallstone disease in Swedish twins: risk is associated with ABCG8 D19H genotype.0.1488277152010ABCG5;ABCG8243839108GA,C
rs118875341763250964241ABCG8umls:C0008350GWASCATA genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease.0.1488277152007ABCG5;ABCG8243839108GA,C
rs118875342286915664241ABCG8umls:C0008350BeFreeABCG8-D19H is a predictor of gallstone recurrence, a major long term postoperative biliary complication.0.1488277152013ABCG5;ABCG8243839108GA,C
rs1471947621852262364241ABCG8umls:C0008350BeFreeVarious polymorphisms (A632V, T400K, D19H, M429V, and C54Y) in the ABCG8 and ABCG5 (Q604E) gene have been found to be associated with several facets of cholesterol metabolism, including baseline cholesterol level, cholesterol kinetics, individual responsiveness of plasma cholesterol to dietary and pharmaceutical interventions for hypercholesterolemia, and increased risk of gallstones.0.1488277152008ABCG8243873860AG
rs22300282016377664241ABCG8umls:C0008350BeFreeIn our study we investigated the contribution of heterozygosity for common variations considered either potentially pathogenic or susceptibility alleles for cholesterol cholelithiasis in adults (c.523A>G (p.Thr175Ala) and c.1954A>G (p.Arg652Gly) in ABCB4, c.1331T>C (p.Val444Ala) in ABCB11 and c.55 G>C (p.Asp19His) in ABCG8) to the aetiology of paediatric idiopathic gallstone disease.0.1488277152010ABCB4787426860TG,C
rs2230028201637768647ABCB11umls:C0008350BeFreeIn our study we investigated the contribution of heterozygosity for common variations considered either potentially pathogenic or susceptibility alleles for cholesterol cholelithiasis in adults (c.523A>G (p.Thr175Ala) and c.1954A>G (p.Arg652Gly) in ABCB4, c.1331T>C (p.Val444Ala) in ABCB11 and c.55 G>C (p.Asp19His) in ABCG8) to the aetiology of paediatric idiopathic gallstone disease.0.0060912732010ABCB4787426860TG,C
rs2230028201637765244ABCB4umls:C0008350BeFreeIn our study we investigated the contribution of heterozygosity for common variations considered either potentially pathogenic or susceptibility alleles for cholesterol cholelithiasis in adults (c.523A>G (p.Thr175Ala) and c.1954A>G (p.Arg652Gly) in ABCB4, c.1331T>C (p.Val444Ala) in ABCB11 and c.55 G>C (p.Asp19His) in ABCG8) to the aetiology of paediatric idiopathic gallstone disease.0.0176312472010ABCB4787426860TG,C
rs2287622201637768647ABCB11umls:C0008350BeFreeIn our study we investigated the contribution of heterozygosity for common variations considered either potentially pathogenic or susceptibility alleles for cholesterol cholelithiasis in adults (c.523A>G (p.Thr175Ala) and c.1954A>G (p.Arg652Gly) in ABCB4, c.1331T>C (p.Val444Ala) in ABCB11 and c.55 G>C (p.Asp19His) in ABCG8) to the aetiology of paediatric idiopathic gallstone disease.0.0060912732010ABCB112168973818AT,G,C
rs2287622201637765244ABCB4umls:C0008350BeFreeIn our study we investigated the contribution of heterozygosity for common variations considered either potentially pathogenic or susceptibility alleles for cholesterol cholelithiasis in adults (c.523A>G (p.Thr175Ala) and c.1954A>G (p.Arg652Gly) in ABCB4, c.1331T>C (p.Val444Ala) in ABCB11 and c.55 G>C (p.Asp19His) in ABCG8) to the aetiology of paediatric idiopathic gallstone disease.0.0176312472010ABCB112168973818AT,G,C
rs22876222016377664241ABCG8umls:C0008350BeFreeIn our study we investigated the contribution of heterozygosity for common variations considered either potentially pathogenic or susceptibility alleles for cholesterol cholelithiasis in adults (c.523A>G (p.Thr175Ala) and c.1954A>G (p.Arg652Gly) in ABCB4, c.1331T>C (p.Val444Ala) in ABCB11 and c.55 G>C (p.Asp19His) in ABCG8) to the aetiology of paediatric idiopathic gallstone disease.0.1488277152010ABCB112168973818AT,G,C
rs41482111761251564240ABCG5umls:C0008350BeFreeTo investigate a possible association between transporter gene polymorphism and gallstone formation, we examined five common polymorphisms in the ABCG5 (Q604E) and ABCG8 (D19H, Y54C, T400K, A632V) genes in patients with gallstone disease (GS).0.1324539892007ABCG8;LOC102725159243844604AG
rs41482111852262364241ABCG8umls:C0008350BeFreeVarious polymorphisms (A632V, T400K, D19H, M429V, and C54Y) in the ABCG8 and ABCG5 (Q604E) gene have been found to be associated with several facets of cholesterol metabolism, including baseline cholesterol level, cholesterol kinetics, individual responsiveness of plasma cholesterol to dietary and pharmaceutical interventions for hypercholesterolemia, and increased risk of gallstones.0.1488277152008ABCG8;LOC102725159243844604AG
rs41482171761251564240ABCG5umls:C0008350BeFreeTo investigate a possible association between transporter gene polymorphism and gallstone formation, we examined five common polymorphisms in the ABCG5 (Q604E) and ABCG8 (D19H, Y54C, T400K, A632V) genes in patients with gallstone disease (GS).0.1324539892007ABCG8243872294CA,G,T
rs41482171852262364241ABCG8umls:C0008350BeFreeVarious polymorphisms (A632V, T400K, D19H, M429V, and C54Y) in the ABCG8 and ABCG5 (Q604E) gene have been found to be associated with several facets of cholesterol metabolism, including baseline cholesterol level, cholesterol kinetics, individual responsiveness of plasma cholesterol to dietary and pharmaceutical interventions for hypercholesterolemia, and increased risk of gallstones.0.1488277152008ABCG8243872294CA,G,T
rs41482171761251564241ABCG8umls:C0008350BeFreeThese findings indicate that the T400K polymorphism in ABCG8 may be associated with the incidence of gallstone disease in males.0.1488277152007ABCG8243872294CA,G,T
rs41490002083701610599SLCO1B1umls:C0008350BeFreeBy using the presence of bilirubin as a phenotype, variants rs6742078 (UGT1A1; P = .003), rs4149056 (SLCO1B1; P = .003), and rs4149000 (SLCO1A2; P = .015) were associated with gallstone composition.0.0052769482010SLCO1A21221295063CT
rs4149000208370166579SLCO1A2umls:C0008350BeFreeBy using the presence of bilirubin as a phenotype, variants rs6742078 (UGT1A1; P = .003), rs4149056 (SLCO1B1; P = .003), and rs4149000 (SLCO1A2; P = .015) were associated with gallstone composition.0.0026384742010SLCO1A21221295063CT
rs41490562083701610599SLCO1B1umls:C0008350BeFreeBy using the presence of bilirubin as a phenotype, variants rs6742078 (UGT1A1; P = .003), rs4149056 (SLCO1B1; P = .003), and rs4149000 (SLCO1A2; P = .015) were associated with gallstone composition.0.0052769482010SLCO1B11221178615TC
rs4149056208370166579SLCO1A2umls:C0008350BeFreeBy using the presence of bilirubin as a phenotype, variants rs6742078 (UGT1A1; P = .003), rs4149056 (SLCO1B1; P = .003), and rs4149000 (SLCO1A2; P = .015) were associated with gallstone composition.0.0026384742010SLCO1B11221178615TC
rs499417640319155ADRB3umls:C0008350BeFreeOur results indicate that the ADRB3 Trp64Arg polymorphism is associated with gallstone disease thereby representing a genetic marker that identifies subjects at higher risk for gallstone formation.0.0026384742007ADRB3837966280AG
rs582385592016377664241ABCG8umls:C0008350BeFreeIn our study we investigated the contribution of heterozygosity for common variations considered either potentially pathogenic or susceptibility alleles for cholesterol cholelithiasis in adults (c.523A>G (p.Thr175Ala) and c.1954A>G (p.Arg652Gly) in ABCB4, c.1331T>C (p.Val444Ala) in ABCB11 and c.55 G>C (p.Asp19His) in ABCG8) to the aetiology of paediatric idiopathic gallstone disease.0.1488277152010ABCB4787452957TC
rs58238559201637768647ABCB11umls:C0008350BeFreeIn our study we investigated the contribution of heterozygosity for common variations considered either potentially pathogenic or susceptibility alleles for cholesterol cholelithiasis in adults (c.523A>G (p.Thr175Ala) and c.1954A>G (p.Arg652Gly) in ABCB4, c.1331T>C (p.Val444Ala) in ABCB11 and c.55 G>C (p.Asp19His) in ABCG8) to the aetiology of paediatric idiopathic gallstone disease.0.0060912732010ABCB4787452957TC
rs58238559201637765244ABCB4umls:C0008350BeFreeIn our study we investigated the contribution of heterozygosity for common variations considered either potentially pathogenic or susceptibility alleles for cholesterol cholelithiasis in adults (c.523A>G (p.Thr175Ala) and c.1954A>G (p.Arg652Gly) in ABCB4, c.1331T>C (p.Val444Ala) in ABCB11 and c.55 G>C (p.Asp19His) in ABCG8) to the aetiology of paediatric idiopathic gallstone disease.0.0176312472010ABCB4787452957TC
rs65447181852262364241ABCG8umls:C0008350BeFreeVarious polymorphisms (A632V, T400K, D19H, M429V, and C54Y) in the ABCG8 and ABCG5 (Q604E) gene have been found to be associated with several facets of cholesterol metabolism, including baseline cholesterol level, cholesterol kinetics, individual responsiveness of plasma cholesterol to dietary and pharmaceutical interventions for hypercholesterolemia, and increased risk of gallstones.0.1488277152008ABCG8243877786TC,G
rs65447181761251564240ABCG5umls:C0008350BeFreeTo investigate a possible association between transporter gene polymorphism and gallstone formation, we examined five common polymorphisms in the ABCG5 (Q604E) and ABCG8 (D19H, Y54C, T400K, A632V) genes in patients with gallstone disease (GS).0.1324539892007ABCG8243877786TC,G
rs67201731761251564240ABCG5umls:C0008350BeFreeTo investigate a possible association between transporter gene polymorphism and gallstone formation, we examined five common polymorphisms in the ABCG5 (Q604E) and ABCG8 (D19H, Y54C, T400K, A632V) genes in patients with gallstone disease (GS).0.1324539892007DYNC2LI1;ABCG5243813262GC
rs67201732049729364240ABCG5umls:C0008350BeFreeRecently, variants of the hepatocanalicular cholesterol hemitransporters ABCG5/8 were linked to gallstone disease; ABCG8 D19H in Caucasians and ABCG5 Q604E in Chinese.0.1324539892010DYNC2LI1;ABCG5243813262GC
rs67201731852262364241ABCG8umls:C0008350BeFreeVarious polymorphisms (A632V, T400K, D19H, M429V, and C54Y) in the ABCG8 and ABCG5 (Q604E) gene have been found to be associated with several facets of cholesterol metabolism, including baseline cholesterol level, cholesterol kinetics, individual responsiveness of plasma cholesterol to dietary and pharmaceutical interventions for hypercholesterolemia, and increased risk of gallstones.0.1488277152008DYNC2LI1;ABCG5243813262GC
rs67420782083701610599SLCO1B1umls:C0008350BeFreeBy using the presence of bilirubin as a phenotype, variants rs6742078 (UGT1A1; P = .003), rs4149056 (SLCO1B1; P = .003), and rs4149000 (SLCO1A2; P = .015) were associated with gallstone composition.0.0052769482010UGT1A10;UGT1A8;UGT1A7;UGT1A6;UGT1A5;UGT1A9;UGT1A4;UGT1A1;UGT1A32233763993GT
rs67420782375327454658UGT1A1umls:C0008350BeFreeSecond, taking advantage of mendelian randomization, we tested whether a genetic variant in the bilirubin glucoronidating enzyme UGT1A1 (rs6742078) was associated with increased plasma bilirubin levels and, in turn, with an increased risk of symptomatic gallstone disease.0.0363620742013UGT1A10;UGT1A8;UGT1A7;UGT1A6;UGT1A5;UGT1A9;UGT1A4;UGT1A1;UGT1A32233763993GT
rs6742078208370166579SLCO1A2umls:C0008350BeFreeBy using the presence of bilirubin as a phenotype, variants rs6742078 (UGT1A1; P = .003), rs4149056 (SLCO1B1; P = .003), and rs4149000 (SLCO1A2; P = .015) were associated with gallstone composition.0.0026384742010UGT1A10;UGT1A8;UGT1A7;UGT1A6;UGT1A5;UGT1A9;UGT1A4;UGT1A1;UGT1A32233763993GT
rs67566292425650764240ABCG5umls:C0008350BeFreeABCG5 rs6756629 is in strong linkage disequilibrium with rs11887534 (D19H), a variant previously associated with gallstone disease risk in populations of European-descent.0.1324539892013ABCG5;ABCG8243837951GA,C
rs693200824851071CETPumls:C0008350BeFreeGenetic variants involved in gallstone formation such as the apolipoprotein B rs693 and CETP rs708272 polymorphisms may be related to the risk of developing GBC in Chilean women.0.0052769482010APOB221009323GA
rs69320082485338APOBumls:C0008350BeFreeGenetic variants involved in gallstone formation such as the apolipoprotein B rs693 and CETP rs708272 polymorphisms may be related to the risk of developing GBC in Chilean women.0.0113682212010APOB221009323GA
rs69322922093348APOEumls:C0008350BeFreeFinally, in meta-analyses, random effects odds ratios for gallstone disease were 0.91 (0.78-1.06) for carriers of APOE ε4 versus non-carriers, and 1.25 (0.95-1.63) for APOB rs693 CT+TT versus CC.0.0248320322013APOB221009323GA
rs708272200824851071CETPumls:C0008350BeFreeGenetic variants involved in gallstone formation such as the apolipoprotein B rs693 and CETP rs708272 polymorphisms may be related to the risk of developing GBC in Chilean women.0.0052769482010CETP1656962376GA
rs70827220082485338APOBumls:C0008350BeFreeGenetic variants involved in gallstone formation such as the apolipoprotein B rs693 and CETP rs708272 polymorphisms may be related to the risk of developing GBC in Chilean women.0.0113682212010CETP1656962376GA
rs9514089220931746555SLC10A2umls:C0008350BeFreeEffects of SLC10A2 variant rs9514089 on gallstone risk and serum cholesterol levels- meta-analysis of three independent cohorts.0.0010857672011SLC10A213103058487TC
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:240)
CHR POS SNPID REF ALT ORI_SNPID PMID P_VALUE P_VALUE_TEXT OR/BETA CI95_TEXT GWAS_INITIAL_SAMPLE_SIZE SUB_POPULATION SUPER_POPULATION GWAS_TRAIT HPO_ID HPO_TERM DO_ID DO_TERM MESH_ID MESH_TERM EFO_ID EFO_TERM DOLITE_TERM RISK_ALLELE PUBLICATION_TYPE AA GENE_SYMBOL TYPE REFGENE
115677932rs7532826AGrs7532826176325095.23E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGFHAD1
123127876rs4506436TCrs4506436176325093.71E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTEPHB2
128105709rs6598902TCrs6598902176325096.57E-08NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCSTX12
143319272rs4660234CTrs4660234176325092.66E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
143616337rs475093GCrs475093176325099.80E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGFAM183A
148959577rs17470284GArs17470284176325093.78E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
154787049rs12021758TCrs12021758176325091.62E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCSSBP3
163566915rs1498942CTrs1498942176325092.43E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
167935310rs6657603TGrs6657603176325092.22E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
168803646rs4926354TCrs4926354176325092.88E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
196366519rs11165512GArs11165512176325093.51E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
1102722923rs11804344CGrs11804344176325093.37E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
1151550673rs12751350GArs12751350176325091.85E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tATUFT1
1151915740rs6686874GArs6686874176325095.51E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
1185864512rs16824658AGrs16824658176325093.76E-07NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGHMCN1
1217510208rs2173289TArs2173289176325093.37E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
1237960958rs12043362GArs12043362176325091.20E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tARYR2
25253424rs1584832ACrs1584832176325093.17E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
26495748rs13394549GArs13394549176325091.43E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
217989466rs12710647TA,C,Grs12710647176325091.05E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
220054057rs10184466GArs10184466176325091.15E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tA,GNA
223409862rs1562755AGrs1562755176325094.91E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
227137616rs12618836GArs12618836176325099.07E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGDPYSL5
227227707rs6716275AGrs6716275176325098.06E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tAMAPRE3
231064313rs2194448CTrs2194448176325091.17E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
233931075rs1550992AGrs1550992176325093.42E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
235198305rs11124408TCrs11124408176325097.15E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
238772915rs7571463CTrs7571463176325094.91E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
244066247rs11887534GC,Trs11887534176325091.00E-14NA2.2[1.80-2.60]280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseasers11887534-CResearch Support, Non-U.S. Gov'tGABCG8
244072576rs4299376GTrs4299376176325091.20E-09NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTABCG8
244073656rs41360247TCrs41360247176325094.07E-09NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTABCG8
244074000rs4953023GArs4953023176325093.40E-09NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGABCG8
244074431rs4245791CTrs4245791176325092.90E-08NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTABCG8
244075217rs17424122TArs17424122176325095.00E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTABCG8
271403181rs370068GCrs370068176325093.04E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
276383940rs4852395TCrs4852395176325093.56E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
2105300588rs1517862GArs1517862176325092.95E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
2107450390rs7608410CTrs7608410176325092.34E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCST6GAL2
2121676655rs895547TCrs895547176325093.45E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tG,AGLI2
2122031769rs6712340CTrs6712340176325091.44E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCTFCP2L1
2135236250rs1840413TCrs1840413176325094.34E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTTMEM163
2157565192rs1543932GArs1543932176325097.12E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
2159918378rs16843641TCrs16843641176325091.28E-09NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTTANC1
2160238718rs1011770AGrs1011770176325091.25E-07NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTBAZ2B
2164300859rs9287831CTrs9287831176325091.76E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
2177991618rs2706137GArs2706137176325093.82E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
2178148288rs7568033CGrs7568033176325092.30E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
2180036775rs10497534GArs10497534176325097.89E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCSESTD1
2186325949rs2059357CGrs2059357176325091.14E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
2186486890rs2193612AGrs2193612176325093.11E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
2188278203rs17464221CTrs17464221176325092.23E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCCALCRL
2190073366rs1878085AGrs1878085176325092.67E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
2198942568rs1371665CTrs1371665176325091.62E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tAPLCL1
2202560854rs6731583TCrs6731583176325092.91E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTMPP4
2208544582rs2432726AGrs2432726176325094.74E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
2224406462rs17230683CTrs17230683176325091.83E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
31377266rs155403GArs155403176325099.41E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGCNTN6
34751010rs3804995CTrs3804995176325096.89E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTITPR1
36488648rs266415TCrs266415176325098.93E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
320384627rs12489904GArs12489904176325094.98E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
327827733rs9817112AGrs9817112176325093.35E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
341613317rs1256388TCrs1256388176325093.19E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tAULK4
371768473rs6775276TArs6775276176325094.59E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tAEIF4E3
3105573413rs16851673GArs16851673176325092.80E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGCBLB
3108714592rs2715701CTrs2715701176325093.54E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTMORC1
3122814053rs4677994CTrs4677994176325099.35E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tC,TPDIA5
3149293316rs16862007TCrs16862007176325093.45E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTWWTR1
3188290842rs7629059GCrs7629059176325092.54E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCLPP
420069271rs1485572TArs1485572176325093.60E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
423996637rs597082TCrs597082176325093.85E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
486177991rs6825968AGrs6825968176325094.18E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
4101700041rs2866240TArs2866240176325092.12E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
4141895912rs17343501CArs17343501176325095.02E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tARNF150
4143779613rs6537129GArs6537129176325096.45E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
4155039514rs7667046AGrs7667046176325097.17E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
4176617540rs17061806TCrs17061806176325091.18E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTGPM6A
4182615493rs715654AGrs715654176325091.09E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
4185335866rs3756091AGrs3756091176325091.74E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tAIRF2
59177932rs3777281TCrs3777281176325091.65E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTSEMA5A
511322276rs28812TCrs28812176325092.06E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGCTNND2
516871264rs253314ACrs253314176325096.46E-09NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGMYO10
576469106rs16874057GArs16874057176325093.48E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
581533735rs6888977CTrs6888977176325093.17E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTATG10
596701779rs10054076GArs10054076176325091.66E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
5106720912rs17159868TCrs17159868176325093.47E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCEFNA5
5107927705rs10477917GArs10477917176325092.08E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
5115792368rs26604GArs26604176325091.11E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTSEMA6A
5157528286rs17229266TGrs17229266176325095.00E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
5161103142rs6893149AGrs6893149176325092.90E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
5170198563rs4868023AGrs4868023176325093.64E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
5174136429rs17063876AGrs17063876176325093.53E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
5177574421rs6601221CTrs6601221176325091.62E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTRMND5B
613420685rs16874136CGrs16874136176325098.51E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCGFOD1
619992265rs520188GArs520188176325093.25E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
620405019rs6456349GArs6456349176325095.02E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tAE2F3
632182759rs206015GArs206015176325096.10E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNOTCH4
635005084rs13210323ACrs13210323176325094.66E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tAANKS1A
684972805rs1408274GTrs1408274176325094.19E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
6108096239rs7758747AGrs7758747176325096.46E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tASCML4
6111789148rs7758483GArs7758483176325099.86E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tAREV3L
6119841070rs10485006TCrs10485006176325093.68E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
6126966308rs4549631TCrs4549631176325093.49E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
6149294576rs729503GArs729503176325091.92E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCUST
6149654120rs11155642GArs11155642176325093.16E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGTAB2
6149779185rs452586GArs452586176325094.96E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tAZC3H12D
718693393rs6979890AGrs6979890176325094.35E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGHDAC9
728119713rs6968494AGrs6968494176325091.73E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGJAZF1
767326739rs2865108CArs2865108176325097.09E-11NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
785080339rs2498553CArs2498553176325093.39E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
796465856rs41345049ATrs41345049176325093.91E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
7105784313rs10258864AGrs10258864176325093.95E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
7109250932rs1568778TCrs1568778176325092.90E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
7122536794rs17145097AGrs17145097176325095.85E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
7135729761rs12537465CG,Trs12537465176325095.25E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
7140014425rs6970317TGrs6970317176325092.89E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
7142337300rs10243991AGrs10243991176325094.92E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
7150444233rs6972271TCrs6972271176325093.84E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
813455181rs41363347GTrs41363347176325097.13E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
814862414rs10888095CArs10888095176325099.81E-07NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCSGCZ
826777509rs12677733GArs12677733176325092.33E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
829743994rs6468360GCrs6468360176325094.55E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
833356074rs6468171AGrs6468171176325091.99E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tAMAK16
836235570rs490767GArs490767176325098.79E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
847384963rs10094715AGrs10094715176325093.33E-16NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
868540972rs10092095AGrs10092095176325094.38E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGCPA6
887854415rs1841019GTrs1841019176325091.00E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
892175393rs13254176GArs13254176176325092.40E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tALRRC69
895110924rs2446834TCrs2446834176325095.79E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
8125801595rs10441517TCrs10441517176325091.35E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
8126611047rs17330462TCrs17330462176325092.64E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
8129110843rs3931281CTrs3931281176325091.09E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGPVT1
8129741536rs7017882TCrs7017882176325091.27E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
8142980434rs935461CTrs935461176325099.61E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
9632131rs10815385GArs10815385176325091.23E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGKANK1
93847878rs10973775GArs10973775176325092.66E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGGLIS3
919448473rs2383096AGrs2383096176325097.77E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tAACER2
934554999rs7044318TCrs7044318176325092.01E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTCNTFR
976262425rs2493449GArs2493449176325093.30E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
979613935rs12378793GCrs12378793176325098.61E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
980039658rs17063627AGrs17063627176325091.03E-08NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGGNA14
983547144rs11138922CTrs11138922176325094.03E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
987553211rs17087898CTrs17087898176325091.78E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNTRK2
991380010rs7849560ATrs7849560176325093.87E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
9100935754rs2231652GCrs2231652176325092.08E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCCORO2A
9108656238rs4598317CArs4598317176325091.35E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
9117825085rs17241442GArs17241442176325096.49E-08NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGTNC
9125480240rs41440452GArs41440452176325093.66E-11NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
1011369870rs9329334CTrs9329334176325091.51E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCCELF2
1013876687rs41506144CGrs41506144176325094.03E-08NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCFRMD4A
1017172221rs7923464TArs7923464176325096.95E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTCUBN
1032202933rs16932781TCrs16932781176325092.97E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTARHGAP12
1044312106rs7079939ACrs7079939176325095.63E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
1061286904rs11006554CTrs11006554176325091.77E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
1069969986rs10998022CTrs10998022176325092.16E-10NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCMYPN
1070742931rs12412103AGrs12412103176325098.75E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGDDX21
1082340707rs11186149TCrs11186149176325096.46E-07NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCSH2D4B
1087383486rs10509523CTrs10509523176325093.68E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTGRID1
1089823147rs945559AGrs945559176325093.13E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
1094920291rs11187300TCrs11187300176325091.98E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
117311898rs10839761TCrs10839761176325094.52E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTSYT9
1110732560rs7122100CArs7122100176325093.77E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
1140783051rs7106270GArs7106270176325095.05E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tALRRC4C
1166333072rs4630309CArs4630309176325094.43E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCCTSF
1167768796rs11228120TCrs11228120176325091.24E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTUNC93B1
1176450908rs12362105GArs12362105176325098.34E-07NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
1177761076rs10899434GArs10899434176325092.50E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNDUFC2-KCTD14
11123026014rs9943547GArs9943547176325092.43E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tACLMP
11134316222rs10894818GArs10894818176325094.77E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGLOC283177
1221231767rs11045726TCrs11045726176325094.20E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTSLCO1B7
1228717111rs2175464CArs2175464176325094.75E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
1251686984rs1362963TCrs1362963176325094.55E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tABIN2
1254811708rs11170895CTrs11170895176325092.40E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGITGA5
1277546841rs7298190CArs7298190176325092.55E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
1280533199rs1113540CTrs1113540176325098.17E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
1286249196rs12314274TCrs12314274176325097.85E-08NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
1296307651rs10859981CTrs10859981176325097.79E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCCCDC38
12114555558rs11066949CTrs11066949176325096.26E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
12115429353rs2384506TCrs2384506176325091.74E-09NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
1326779776rs12873948AGrs12873948176325091.01E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
1337978531rs9532047ATrs9532047176325091.48E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
1340930271rs9549185TCrs9549185176325091.10E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTTTL
1351302310rs3118077GArs3118077176325091.96E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGDLEU7
1364901015rs17084970CTrs17084970176325091.95E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
1372257236rs17088392TCrs17088392176325091.63E-10NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTDACH1
1383191238rs1333587GTrs1333587176325094.86E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
13108100801rs9989059TCrs9989059176325096.13E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCFAM155A
1434728231rs11625217GArs11625217176325092.54E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
1478763870rs12588277GArs12588277176325092.91E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
1481604138rs1957547AGrs1957547176325094.87E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCTSHR
1495016780rs2896287GArs2896287176325092.57E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
1499505534rs9324006GArs9324006176325091.31E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
1533412013rs2444955TGrs2444955176325093.97E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
1534985743rs2028099GCrs2028099176325095.26E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
1557957824rs9302201CTrs9302201176325091.14E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCGCOM1
1563764505rs751940TCrs751940176325093.51E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
1579396743rs7172107GArs7172107176325093.72E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
1580852918rs6495506GArs6495506176325097.59E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tAARNT2
1594804241rs6497188AGrs6497188176325092.93E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
1599164370rs7180993AGrs7180993176325093.63E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
163112197rs13335800ATrs13335800176325091.19E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
168590873rs8061765GArs8061765176325091.60E-07NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
1610993488rs7189406GArs7189406176325098.33E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tACIITA
1615512575rs3844608AGrs3844608176325093.17E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
1621737414rs4783414TCrs4783414176325098.65E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTOTOA
1627354361rs3024547CTrs3024547176325094.54E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTIL4R
1655767078rs9938863CTrs9938863176325093.98E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tT,CCES1P2
1686024616rs12599351TCrs12599351176325093.09E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
1717913057rs6502632TCrs6502632176325092.93E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTLRRC48
1730635730rs8073013AGrs8073013176325091.57E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tARHBDL3
1731902993rs12450179AGrs12450179176325091.89E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGASIC2
1749780250rs9906298TCrs9906298176325094.10E-10NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCCA10
1754833348rs2049063CArs2049063176325094.63E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
1756142411rs2585842CArs2585842176325093.80E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
1761569732rs4351GArs4351176325094.76E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGACE
1763288648rs7208337TCrs7208337176325095.46E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
1770660902rs4793297AGrs4793297176325098.01E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGSLC39A11
1772083792rs8080915TCrs8080915176325092.85E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
1772548847rs7221379CGrs7221379176325094.68E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
182921444rs2282635TCrs2282635176325098.01E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTLPIN2
186158716rs8083296ACrs8083296176325095.31E-09NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCL3MBTL4
186776036rs11081271GArs11081271176325092.26E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
1813992052rs12457555CGrs12457555176325093.33E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
1856996526rs1043334TGrs1043334176325091.60E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tALMAN1
1857648275rs17066440TCrs17066440176325091.68E-10NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
1861013635rs7231949CTrs7231949176325093.45E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCKDSR
1952573067rs2043298CArs2043298176325093.94E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTZNF841
1953330669rs2013647CTrs2013647176325091.20E-08NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
201323192rs6109526TCrs6109526176325093.94E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTLOC100507495
203255905rs2236087GArs2236087176325096.26E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGC20orf194
2041243024rs6102950AGrs6102950176325098.49E-05NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tAPTPRT
2049906076rs6063623CGrs6063623176325091.76E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGNA
2058274520rs12481511TCrs12481511176325091.03E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTPHACTR3
2058669008rs1475029AGrs1475029176325095.67E-07NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGLOC729296
2127271030rs7280059AGrs7280059176325091.42E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tAAPP
2147052223rs2330186AGrs2330186176325091.41E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
2147323009rs7278253GArs7278253176325091.00E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tGPCBP3
2224022631rs738785CTrs738785176325091.98E-07NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTGUSBP11
2236533785rs132617CTrs132617176325092.22E-04NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tCNA
2244880526rs12159288TGrs12159288176325092.14E-06NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tTNA
2249977557rs135851ACrs135851176325093.32E-10NANANA280 cases; 360 controlsNOPOP(640)ALL(640)NOPOP(640)ALL(640)GallstonesHPOID:0001081CholelithiasisDOID:11151cholecystolithiasisD042882GallstonesEFOID:0004210gallstonesGallbladder diseaseNAResearch Support, Non-U.S. Gov'tANA
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Chemical(Total Drugs:14)
CUI ChemicalName ChemicalID CasRN DiseaseName DiseaseID DirectEvidence PubMedIDs
C0008350celecoxibD000068579-cholelithiasisMESH:D002769marker/mechanism11177350
C0008350cyclosporineD01657259865-13-3cholelithiasisMESH:D002769marker/mechanism19541577
C0008350indinavirD019469150378-17-9cholelithiasisMESH:D002769marker/mechanism12173151
C0008350medroxyprogesterone acetateD01725871-58-9cholelithiasisMESH:D002769marker/mechanism1385654
C0008350morphineD00902057-27-2cholelithiasisMESH:D002769marker/mechanism10853216
C0008350octreotideD01528283150-76-9cholelithiasisMESH:D002769marker/mechanism10923237
C0008350octreotideD01528283150-76-9cholelithiasisMESH:D002769therapeutic11788010
C0008350progesteroneD01137457-83-0cholelithiasisMESH:D002769marker/mechanism221871
C0008350rifampinD01229313292-46-1cholelithiasisMESH:D002769marker/mechanism6452153
C0008350sulindacD01346738194-50-2cholelithiasisMESH:D002769marker/mechanism10445564
C0008350tacrolimusD016559109581-93-3cholelithiasisMESH:D002769marker/mechanism19541577
C0008350morphineD00902057-27-2gallstonesMESH:D042882marker/mechanism3431227
C0008350octreotideD01528283150-76-9gallstonesMESH:D042882marker/mechanism11148435
C0008350octreotideD01528283150-76-9gallstonesMESH:D042882therapeutic1628089
FDA approved drug and dosage information(Total Drugs:2)
DiseaseID Drug_name active_ingredients strength Dosage Form/Route Marketing Status TE code RLD RS
MESH:D002769celebrexcelecoxib100MGCAPSULE;ORALPrescriptionABYesNo
MESH:D002769celebrexcelecoxib100MGCAPSULE;ORALPrescriptionNoneNoNo
FDA labeling changes(Total Drugs:2)
DiseaseID Pediatric_Labeling_Date Trade_Name Generic_Name_or_Proper_Name Indications Studied Label Changes Summary Product Labeling BPCA(B) PREA(P) BPCA(B) and PREA(P) Pediatric Rule (R) Sponsor Pediatric Exclusivity Granted Date NNPS
MESH:D00276912/15/2006celebrexcelecoxibRelief of the signs and symptoms of juvenile rheumatoid arthritis (JRA)New indication in 2 years and older Has not been studied in patients < 2 years, in patients with body weight < 10 kg, or in patients with active systemic features Celecoxib should be used only with caution in patients with systemic onset JRA due to the risk for serious adverse reactions including the risk of disseminated intravascular coagulation The long-term cardiovascular toxicity in children has not been evaluated; it is unknown if the long-term risk may be similar to that seen in adults New 50 mg capsule developed Information on adding contents of a capsule to applesauce. for patients with difficulty swallowing capsules Information on dose, clinical studies, PK parameters, AEsLabelingB---Pfizer08/23/2006FALSE'
MESH:D00276912/15/2006celebrexcelecoxibRelief of the signs and symptoms of juvenile rheumatoid arthritis (JRA)New indication in 2 years and older Has not been studied in patients < 2 years, in patients with body weight < 10 kg, or in patients with active systemic features Celecoxib should be used only with caution in patients with systemic onset JRA due to the risk for serious adverse reactions including the risk of disseminated intravascular coagulation The long-term cardiovascular toxicity in children has not been evaluated; it is unknown if the long-term risk may be similar to that seen in adults New 50 mg capsule developed Information on adding contents of a capsule to applesauce. for patients with difficulty swallowing capsules Information on dose, clinical studies, PK parameters, AEsLabelingB---Pfizer08/23/2006FALSE'